PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

Abroad (travel likely)Recruiting

Conditions

Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CorEvitas, LLC, Waltham, Massachusetts, United States
Contact: Study coordinator (Regulatory Corevitas)
Study coordinator · corevitasregistrytrials@corevitas.com
CorEvitas, LLC, Waltham, Massachusetts, United States
Contact: Study coordinator (Cathy Cheney) · corevitasregistrytrials@corevitas.com · 508-555-1212
Study coordinator · corevitasregistrytrials@corevitas.com · 508-555-1212

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Fountain Valley, United States

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Ciudad Autonoma de Buenos Aires, Argentina · Ciudad Autonoma de Buenos Aires, Argentina

A Phase 3 Clinical Study of QL2106 Injection

Plaque Psoriasis

Abroad (travel likely)RecruitingPHASE3

Jining, China

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Autoimmune Diseases · Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA)

Abroad (travel likely)RecruitingPHASE1

Charlestown, Australia · Birtinya, Australia